PreAnalytiX: PreAnalytiX is now a member of BLOODPAC!

- - - - Blood RNA / miRNA PAXgene Blood RNA Tube (IVD) PAXgene Blood RNA Kit (IVD) FDA PAXgene 96 Blood RNA Kit QIAsymphony PAXgene Blood RNA Kit PAXgene Blood miRNA Kit Accessories ccfDNA PAXgene Blood ccfDNA Tube (RUO) QIAsymphony PAXgene Blood ccfDNA Kit Accessories DNA PAXgene Blood DNA Tube (IVD) PAXgene Blood DNA Tube PAXgene Blood DNA Kit Accessories
    - - Urine Cell-free DNA PAXgene Urine Liquid Biopsy Set (RUO) Accessories
        03/30/2023
        PreAnalytiX is now a member of BLOODPAC!
        The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium’s mission is to accelerate the development, validation and accessibility of liquid biopsy assays to improve the outcomes of patients with cancer.
        
        BLOODPAC leads a collaborative infrastructure that enables sharing of information between stakeholders in nonprofit, industry, academic and regulatory agencies. In addition to developing standards, BLOODPAC works collaboratively to broaden awareness and implementation of the suggested guidelines and establish a wider chain of feedback and discussion in the liquid biopsy community. BLOODPAC’s unique approach to collaboration in the field has led to the organization’s success.
        We are excited to announce that we are BLOODPAC's newest member! PreAnalytiX shares BLOODPAC's goal of accelerating the adoption of liquid biopsy assays to benefit patients and advance healthcare. PreAnalytiX is highly invested in standardizing the pre-analytical steps of liquid biopsy workflows and looking forward to being part of BLOODPAC!
        Read More: How We Work — BLOODPAC
    - - Saliva DNA PAXgene Saliva Collector (MBA)
        03/30/2023
        PreAnalytiX is now a member of BLOODPAC!
        The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium’s mission is to accelerate the development, validation and accessibility of liquid biopsy assays to improve the outcomes of patients with cancer.
        
        BLOODPAC leads a collaborative infrastructure that enables sharing of information between stakeholders in nonprofit, industry, academic and regulatory agencies. In addition to developing standards, BLOODPAC works collaboratively to broaden awareness and implementation of the suggested guidelines and establish a wider chain of feedback and discussion in the liquid biopsy community. BLOODPAC’s unique approach to collaboration in the field has led to the organization’s success.
        We are excited to announce that we are BLOODPAC's newest member! PreAnalytiX shares BLOODPAC's goal of accelerating the adoption of liquid biopsy assays to benefit patients and advance healthcare. PreAnalytiX is highly invested in standardizing the pre-analytical steps of liquid biopsy workflows and looking forward to being part of BLOODPAC!
        Read More: How We Work — BLOODPAC
    - - Tissue Fixation & Stabilization PAXgene Tissue FIX Container PAXgene Tissue STABILIZER Concentrate RNA / miRNA PAXgene Tissue RNA/miRNA Kit DNA PAXgene Tissue DNA Kit
        Tissue Atlas: Stained sections of mirrored samples from formalin fixed, paraffin-embedded (FFPE) and PAXgene Tissue fixed, paraffin-embedded (PFPE) tissues.
    - - Bone Marrow RNA PAXgene Bone Marrow RNA Tube PAXgene Bone Marrow RNA Kit
        03/30/2023
        PreAnalytiX is now a member of BLOODPAC!
        The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium’s mission is to accelerate the development, validation and accessibility of liquid biopsy assays to improve the outcomes of patients with cancer.
        
        BLOODPAC leads a collaborative infrastructure that enables sharing of information between stakeholders in nonprofit, industry, academic and regulatory agencies. In addition to developing standards, BLOODPAC works collaboratively to broaden awareness and implementation of the suggested guidelines and establish a wider chain of feedback and discussion in the liquid biopsy community. BLOODPAC’s unique approach to collaboration in the field has led to the organization’s success.
        We are excited to announce that we are BLOODPAC's newest member! PreAnalytiX shares BLOODPAC's goal of accelerating the adoption of liquid biopsy assays to benefit patients and advance healthcare. PreAnalytiX is highly invested in standardizing the pre-analytical steps of liquid biopsy workflows and looking forward to being part of BLOODPAC!
        Read More: How We Work — BLOODPAC
- - - Knowledge
      Blood RNA RNA-Application ccfDNA (RUO) miRNA DNA
      Saliva DNA
      Tissue Fixation and Stabilization RNA and miRNA DNA Tissue Atlas
      Bone Marrow RNA
- Resources
- - - Company
      About Us Value Innovation
      Testimonials PAXgene Blood RNA System PAXgene Blood ccfDNA System
      Patents
- News & Events

Filter by categories

Filter by date

The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium’s mission is to accelerate the development, validation and accessibility of liquid biopsy assays to improve the outcomes of patients with cancer.

BLOODPAC leads a collaborative infrastructure that enables sharing of information between stakeholders in nonprofit, industry, academic and regulatory agencies. In addition to developing standards, BLOODPAC works collaboratively to broaden awareness and implementation of the suggested guidelines and establish a wider chain of feedback and discussion in the liquid biopsy community. BLOODPAC’s unique approach to collaboration in the field has led to the organization’s success.

We are excited to announce that we are BLOODPAC's newest member! PreAnalytiX shares BLOODPAC's goal of accelerating the adoption of liquid biopsy assays to benefit patients and advance healthcare. PreAnalytiX is highly invested in standardizing the pre-analytical steps of liquid biopsy workflows and looking forward to being part of BLOODPAC!